Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
432,001,939
-
Number of holders
-
254
-
Total 13F shares, excl. options
-
268,200,640
-
Shares change
-
+3,377,339
-
Total reported value, excl. options
-
$10,687,984,091
-
Value change
-
+$139,946,049
-
Put/Call ratio
-
20%
-
Number of buys
-
153
-
Number of sells
-
-88
-
Price
-
$39.85
Significant Holders of Royalty Pharma plc - Common Stock (RPRX) as of Q4 2021
293 filings reported holding RPRX - Royalty Pharma plc - Common Stock as of Q4 2021.
Royalty Pharma plc - Common Stock (RPRX) has 254 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 268,200,640 shares
of 432,001,939 outstanding shares and own 62.08% of the company stock.
Largest 10 shareholders include MORGAN STANLEY (56,230,690 shares), VANGUARD GROUP INC (29,636,565 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (24,842,715 shares), FMR LLC (22,079,785 shares), BlackRock Inc. (16,715,324 shares), VIKING GLOBAL INVESTORS LP (10,315,378 shares), Berkshire Hathaway Inc (8,648,268 shares), STATE STREET CORP (7,077,330 shares), SIGULER GUFF ADVISERS, LLC (6,761,970 shares), and JPMORGAN CHASE & CO (5,422,203 shares).
This table shows the top 254 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.